课题基金 / 基金详情

Analysis of CD29/VLA integrin in T cell immune regulation and its clinical significance

Analysis of CD29/VLA integrin in T cell immune regulation and its clinical significance
CD29/VLA整合素在T细胞免疫调节中的作用分析及其临床意义
批准号:
11307009
负责人:
MORIMOTO Chikao
金额:
$23.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MORIMOTO Chikao的其他基金

相似基金

相关文献

中文摘要
翻译
附着于骨髓(BM)基质细胞对于B细胞祖细胞(pro-B)的正常生长和发育至关重要。然而,接触促进pro-B细胞增殖的分子机制尚未完全了解。本研究发现,与正常骨髓基质细胞和KM 102细胞贴附后,Reh细胞的生长明显增强,而与KM 102细胞贴附后,Reh细胞的生长明显增强。用抗整合素β 1或α 5单克隆抗体(mAb)预处理Reh细胞,而不是α 4或ICAM-1 mAb,消除了这种增殖增强。此外,间质附着导致细胞周期G(1)期缩短,cdk 2活性显著增加,cdk抑制剂p27-GST蛋白降解,p27(Kip 1)蛋白水平降低。此外,通过固定化抗体的α 5固相交联也导致细胞外信号调节(ERK)-2激酶磷酸化,cdk 2活性增加,p27(Kip 1)蛋白水平降低,以及通过用PD 98059处理抑制的增殖增强,整合素α 5 β 1介导的基质接触通过ERK-2的活化促进B细胞祖细胞的增殖,其反过来调节细胞周期调节机制,包括cdk 2活性的诱导和p27(Kip 1)的降解,并促进细胞周期进程的G(1)期的加速。
英文摘要
Attachment to bone marrow(BM)stromal cells is crucial for the normal growth and development of B-cell progenitors(pro-B). However, the molecular mechanisms by which contact facilitates the proliferation of pro-B cells are not completely understood. This study was performed to investigate this interaction.Attachment to both KM102 and normal BM stromal cells significantly promoted the growth of Reh cells. Pretreatment of Reh cells with anti-integrin beta1 or alpha5 monoclonal antibody(mAb), but not alpha4 or ICAM-1 mAb, abrogated this enhancement of proliferation. Furthermore, stroma attachment resulted in shortening of the G(1)phase of cell cycle, significant increases cdk2 activity, degradation of cdk inhibitor p27-GST protein, and decrease in levels of p27(Kip1)protein. In addition, solid-phase cross-linking of alpha5 via immobilized antibody also resulted in extracellular signal-regulated(ERK)-2 kinase phosphorylation, increase in cdk2 activity, decrease in levels of p27(Kip1)protein, and enhanced proliferation that was inhibited by treatment with PD98059, a specific ERK inhibitor.Integrin alpha5beta1-mediated stroma contact promotes the proliferation of B-cell progenitors through the activation of ERK-2, which in tum modulates cell cycle regulation machinery including induction of cdk2 activity and degradation of p27(Kip1)and contributing to acceleration of the G(1)phase of cell cycle progression.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Qing Y-W,Kitagawa M,Higashi M,Ishii G,Morimoto C,Harigaya K: "Activation of mitogen-activated protein kinas through α5β1 integrin is required for the cell cycle progression of B progenita cell line, Reh, on human marrow stromal cells"Exp.Hematol. 28. 1147
Qing Y-W、Kitakawa M、Higashi M、Ishii G、Morimoto C、Harigaya K:“人骨髓基质细胞上的 B 祖细胞系 Reh 的细胞周期进展需要通过 α5β1 整合素激活有丝分裂原激活蛋白激酶”实验。 28. 1147
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iwata S,Ohashi Y,Kamiguchi K,Morimoto C: "Beta 1-integrin-mediated cell signaling in T lymphocytes"J Dermatol Sci. 23. 75-86 (2000)
Iwata S、Ohashi Y、Kamiguchi K、Morimoto C:“T 淋巴细胞中 Beta 1-整合素介导的细胞信号传导”J Dermatol Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Munakata Y, Iwata S, Dobers J, Ishii T, Nori M, Tanaka H, Morimoto C: "Novel in Vitro effects of bucillamine : Inhibitory iffects on proinflammatory cytokine production and tranendothelial migration of T Cell."Arthr.and Rheum. 43. 1616-1623 (2000)
Munakata Y、Iwata S、Dobers J、Ishii T、Nori M、Tanaka H、Morimoto C:“布西拉明的新型体外作用:对促炎细胞因子产生和 T 细胞跨内皮迁移的抑制作用。”Arthr. 和 Rheum。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ikushima H, Munakata Y, Ishii T, Iwata S, Terashima M, Tanaka H, Schlossman SF, Morimoto C.: "Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation"Proc.Natl.Acad.Sci.. 97. 8439-8444 (2000)
Ikushima H、Munakata Y、Ishii T、Iwata S、Terashima M、Tanaka H、Schlossman SF、Morimoto C.:“6-磷酸甘露糖/胰岛素样生长因子 II 受体对 CD26 的内化有助于 T 细胞激活”Proc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
    • 批准号:
      24659401
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
    • 批准号:
      22650223
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.12万
    • 财政年份:
      2010
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
    Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
    • 批准号:
      17109011
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $71.72万
    • 财政年份:
      2005
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    国内基金
    中药五谷虫提取物基于Angptl2/integrin α5β1系统促进溃疡创面血管新生与愈合的机制研究
    • 批准号:
      82204822
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      宋明智
    • 依托单位:
    CCL20通过受体Integrin α5/β1诱导肺成纤维细胞活化促进肺纤维化的机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      刘姗姗
    • 依托单位:
    基于Integrinα5β1/AKT调控力学-生物学信号传递探讨三石猫复方抑制高基质硬度致肝癌侵袭转移的机制
    基于Integrinα5β1/AKT调控力学-生物学信号传递探讨三石猫复方抑制高基质硬度致肝癌侵袭转移的机制